World News

The device combines an adjustable upper-arm cuff and monitoring unit in a single assembly, eliminating external tubes and cables.

The findings extend previous research into HTD1801’s potential to address kidney impairment associated with metabolic abnormalities.

Kaigene is developing the antibody for long-acting subcutaneous administration to maintain target inhibition over extended intervals and reduce treatment frequency.

Gilead is exploring HCXT-2001 as a potential oral treatment that could complement its existing inflammation portfolio, which includes programmes targeting IBD, type 2 inflammatory diseases, lupus and B cell-mediated autoimmune conditions.

Researchers used patient-derived tumor tissue to investigate whether the technology could improve drug delivery and make tumors more responsive to treatment.

CMR Surgical will continue to develop its products and manage commercialisation in markets outside the US.

Xodus Medical develops surgical products used in patient positioning, sterile processing and operating rooms, giving Steris a broader range of consumables for hospital customers.

Under the agreement, Labcorp will pay US$722 million in cash upfront for BioReference’s clinical and women’s health testing businesses, urology services, corrections testing operations and related assets.

The programme includes a Phase I trial in healthy volunteers, followed by a Phase Ib trial in hospitalised patients with acute liver injury, acute liver failure or acute-on-chronic liver failure.

Manufactured by BioFire Defense, a bioMérieux subsidiary, the panel tests for 16 pathogens from a single whole blood sample in approximately one hour.